Last reviewed · How we verify

NCT05134324

The Effects of rTMS and tDCS Copuled With Robotic Therapy In Patients With Stroke

Status unknown NA Last updated 24 November 2021
What this trial tests

NA trial testing active rTMS in Chronic Stroke in 40 participants. Status unknown.

Timeline
25 May 2021
Primary endpoint
25 February 2022
25 May 2022

Quick facts

Lead sponsorGaziler Physical Medicine and Rehabilitation Education and Research Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date25 May 2021
Primary completion25 February 2022
Estimated completion25 May 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gaziler Physical Medicine and Rehabilitation Education and Research Hospital

Who can join

18 and older, any sex, with Chronic Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the effect of rTMS and tDCS coupled with robotic therapy on upper extremity functional recovery

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of active rTMS

Trials testing the same drug.

Other recruiting trials for Chronic Stroke

Currently open trials in the same condition.

Other Gaziler Physical Medicine and Rehabilitation Education and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05134324.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing